| 27/04/22 | 17:08:08 | 27 Apr 2022 | | ARECOR 2021 ANNUAL REPORT AND NOTICE OF AGM | RNS |
| 27/04/22 | 07:00:09 | 27 Apr 2022 | | Arecor on Investor Meet Company Platform | RNS |
| 25/04/22 | 07:00:07 | 25 Apr 2022 | | FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021 | RNS |
| 12/04/22 | 07:00:07 | 12 Apr 2022 | | ARECOR ANNOUNCES ORAL PRESENTATION AT ATTD 2022 | RNS |
| 29/03/22 | 07:00:10 | 29 Mar 2022 | | Notice of Preliminary Results | RNS |
| 28/03/22 | 07:00:09 | 28 Mar 2022 | | Arecor wins at CambridgeshireLive Business Awards | RNS |
| 23/03/22 | 07:00:03 | 23 Mar 2022 | | Arecor Granted Key U.S Patent | RNS |
| 20/01/22 | 07:01:06 | 20 Jan 2022 | | ARECOR PROVIDES BUSINESS UPDATE | RNS |
| 20/01/22 | 07:00:09 | 20 Jan 2022 | | ARECOR COMMENCES US PHASE I TRIAL OF AT247 | RNS |
| 21/12/21 | 07:00:04 | 21 Dec 2021 | | Arecor Provides Update on Agreement with Hikma | RNS |
| 14/12/21 | 07:00:06 | 14 Dec 2021 | | Arecor Collaborates with Global Technology Leader | RNS |
| 25/11/21 | 07:00:04 | 25 Nov 2021 | | Grant of Options, PDMR Dealing | RNS |
| 11/11/21 | 07:00:04 | 11 Nov 2021 | | Holdings in Company | RNS |
| 11/11/21 | 07:00:03 | 11 Nov 2021 | | Arecor Granted Key Canadian Patent | RNS |
| 01/11/21 | 07:00:12 | 1 Nov 2021 | | Arecor announces formulation study collaboration | RNS |
| 25/10/21 | 16:25:28 | 25 Oct 2021 | | Exercise of options, PDMR, Total Voting Rights | RNS |
| 11/10/21 | 09:18:07 | 11 Oct 2021 | | Arecor’s Polysaccharide Vaccine Patent Upheld | RNS |
| 23/09/21 | 07:00:08 | 23 Sept 2021 | | INTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2021 | RNS |
| 22/09/21 | 16:41:53 | 22 Sept 2021 | | Second Price Monitoring Extn | RNS |
| 22/09/21 | 16:36:37 | 22 Sept 2021 | | Price Monitoring Extension | RNS |
| 22/09/21 | 14:06:24 | 22 Sept 2021 | | Second Price Monitoring Extn | RNS |
| 22/09/21 | 14:00:46 | 22 Sept 2021 | | Price Monitoring Extension | RNS |
| 22/09/21 | 11:06:22 | 22 Sept 2021 | | Second Price Monitoring Extn | RNS |
| 22/09/21 | 11:00:57 | 22 Sept 2021 | | Price Monitoring Extension | RNS |
| 22/09/21 | 09:06:03 | 22 Sept 2021 | | Second Price Monitoring Extn | RNS |
| 22/09/21 | 09:00:28 | 22 Sept 2021 | | Price Monitoring Extension | RNS |
| 20/09/21 | 14:05:49 | 20 Sept 2021 | | Second Price Monitoring Extn | RNS |
| 20/09/21 | 14:00:31 | 20 Sept 2021 | | Price Monitoring Extension | RNS |
| 20/09/21 | 07:00:08 | 20 Sept 2021 | | Positive results for AT278 clinical trial | RNS |
| 09/09/21 | 07:00:05 | 9 Sept 2021 | | FDA clearance of IND | RNS |
| 07/09/21 | 07:00:03 | 7 Sept 2021 | | EXCLUSIVE COLLABORATION WITH INTAS PHARMACEUTICALS | RNS |
| 03/09/21 | 07:00:07 | 3 Sept 2021 | | Notice of Interim Results | RNS |
| 27/08/21 | 13:40:41 | 27 Aug 2021 | | APPOINTMENT OF GRANT THORNTON AS AUDITOR | RNS |
| 14/07/21 | 07:00:03 | 14 Jul 2021 | | Business Update | RNS |
| 29/06/21 | 12:05:06 | 29 Jun 2021 | | Director Dealing | RNS |
| 10/06/21 | 07:00:10 | 10 Jun 2021 | | APPOINTS DR. LINDSEY FOULKES AS COO | RNS |
| 09/06/21 | 07:00:03 | 9 Jun 2021 | | Director Dealing | RNS |
| 07/06/21 | 07:00:11 | 7 Jun 2021 | | Arecor announces collaboration with Par | RNS |
| 04/06/21 | 17:21:49 | 4 Jun 2021 | | Holding(s) in Company | RNS |
| 04/06/21 | 17:03:57 | 4 Jun 2021 | | Holdings in Company | RNS |
| 04/06/21 | 16:25:53 | 4 Jun 2021 | | Holdings in Company | RNS |
| 03/06/21 | 12:31:18 | 3 Jun 2021 | | Standard form for notification of major holdings | RNS |
| 03/06/21 | 07:00:06 | 3 Jun 2021 | | First Day of Dealings on AIM | RNS |
| 20/05/21 | 09:00:08 | 20 May 2021 | | Arecor announces collaboration with Lilly | RNS |
| 17/05/21 | 07:00:15 | 17 May 2021 | | Arecor Announces Intention to Float on AIM | RNS |
